Bethesda, MD (PRWEB)
September 19, 2017
CME Outfitters (CMEO), a leading accredited provider in continuing medical education, has launched a unique Biosimilars Education Hub where clinicians can find up to date listings of all upcoming and currently available activities on biosimilar agent. In addition to these free educational activities, the hub also features resources that clinicians can use in practice to educate their patients.
While biologic agents have been shown to be highly effected in the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and ulcerative colitis, increased healthcare spending has caused many insurance companies to restrict these pharmaceuticals due to high costs. The first biosimilar monoclonal antibody for inflammatory diseases was approved by the FDA in April 2016, with three additional biosimilars approved since, and several still in development.
Many clinicians and patients are unfamiliar with these new biosimilar agents and both parties have important questions and concerns: What do the terms interchangeability and extrapolation mean for my practice? Are these agents as efficacious as their reference biologic? How does the development and manufacture process of a biosimilar compare to the original biologic? Can patients expect to see real cost savings? How does a clinician even go about ordering biosimilar agents? Additionally, patients have reported a significant lack of knowledge amongst their clinicians on the topic of biosimilars as they may pertain to the treatment of their inflammatory disease or decreased cost of care.
The Biosimilars Hub aims to provide clinicians with the much-needed answers to their important questions on the various aspects of biosimilars and to educate them on how to best implement them into their clinical practice. In addition to a number of free activities, visitors to the hub will also find several free, downloadable resources to use in your practice and to educate your patients on the interchangeability, safety, efficacy, and potential cost savings when using biosimilars to treat inflammatory diseases.
Visit the Biosimilars Hub today at http://www.cmeoutfitters.com/BioSimHub to view or participate in these free activities.
About CME Outfitters, LLC
CME Outfitters develops and distributes live, recorded and web-based, outcomes- and…